Melatonin is the body's natural sleep hormone — and one of the most widely used treatments for circadian rhythm sleep disorders. Available over the counter in many countries and as prescription formulations in others, melatonin and its receptor agonists are a major segment of the circadian rhythm sleep disorders market, and they continue to evolve.
Melatonin helps reset the body clock and is used for jet lag, delayed sleep phase disorder, and shift work disorder. Prolonged-release formulations and melatonin receptor agonists (such as ramelteon and tasimelteon) offer more consistent effects. According to circadian rhythm sleep disorders market research, melatonin-based treatments represent a significant share of the market, driven by their safety profile and accessibility. Growth is supported by new formulations and expanded clinical evidence.
Innovation includes prolonged-release melatonin, combination products, and digital tools for timing doses.
Challenges include variable product quality, regulatory differences, and limited evidence for some uses.
Yet the trend is clear: melatonin will remain central to treatment, and the market is expected to benefit as formulations improve.
People Also Ask
Q: Is melatonin effective for circadian rhythm sleep disorders?
A: Yes — melatonin helps reset the body clock and is used for jet lag, delayed sleep phase disorder, and shift work disorder.
Q: What is the difference between melatonin and melatonin receptor agonists?
A: Melatonin is the natural hormone, while receptor agonists are synthetic drugs that mimic its effects with more consistent action.
Tags: #Melatonin #SleepHormone #CircadianRhythm #JetLag #SleepTreatment #MarketTrends
